This study aimed to evaluate the cost-effectiveness of unilateral cochlear implants (UCIs) in Chinese adults with severe or profound sensorineural hearing loss, which helps to inform the introduction of a new intervention for underserved adult patients with severe hearing loss.
✦ The floor
Discussion
Signed responses from readers of the wire.
No immediate practice change for non-Chinese-market clinicians; findings inform health policy and reimbursement decisions in China but do not alter implant candidacy criteria or fitting protocols elsewhere.
As cochlear implant programs expand across Asia, country-specific cost-effectiveness data are essential for guiding government reimbursement policy and equitable access.
- 01Decision-analytical model assessed cost-effectiveness of unilateral cochlear implants in Chinese adults.
- 02Target population: adults with severe-to-profound sensorineural hearing loss (SNHL) in China.
- 03Findings are directly relevant to Chinese health-technology assessment and reimbursement debates.
- 04Published in Otolaryngology–Head and Neck Surgery (2026).
- 05Results may differ markedly from Western cost-effectiveness estimates due to different cost structures and utilities.
Unilateral cochlear implants are being evaluated as cost-effective for Chinese adults with severe or profound sensorineural hearing loss.
studypartially supported- PMID
- 42735054
- DOI
- 10.1002/ohn.70427.
- Journal
- Otolaryngology–Head and Neck Surgery
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Chinese adults with severe or profound sensorineural hearing loss
- Intervention
- Unilateral cochlear implantation
- Comparator
- No implant / conventional hearing aids (modeled comparator)
Primary outcomes
Cost-effectiveness ratio (e.g., cost per QALY gained); Long-term health utility outcomes modeled over time